Researcher profile

Yijin Huang

Yijin Huang contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

AADG: Automatic Augmentation for Domain Generalization on Retinal Image Segmentation

Convolutional neural networks have been widely applied to medical image segmentation and have achieved considerable performance. However, the performance may be significantly affected by the domain gap between training data (source domain) and testing data (target domain). To address this issue, we propose a data manipulation based domain generalization method, called Automated Augmentation for Domain Generalization (AADG). Our AADG framework can effectively sample data augmentation policies that generate novel domains and diversify the training set from an appropriate search space. Specifically, we introduce a novel proxy task maximizing the diversity among multiple augmented novel domains as measured by the Sinkhorn distance in a unit sphere space, making automated augmentation tractable. Adversarial training and deep reinforcement learning are employed to efficiently search the objectives. Quantitative and qualitative experiments on 11 publicly-accessible fundus image datasets (four for retinal vessel segmentation, four for optic disc and cup (OD/OC) segmentation and three for retinal lesion segmentation) are comprehensively performed. Two OCTA datasets for retinal vasculature segmentation are further involved to validate cross-modality generalization. Our proposed AADG exhibits state-of-the-art generalization performance and outperforms existing approaches by considerable margins on retinal vessel, OD/OC and lesion segmentation tasks. The learned policies are empirically validated to be model-agnostic and can transfer well to other models. The source code is available at https://github.com/CRazorback/AADG.

preprint2022arXiv

LesionPaste: One-Shot Anomaly Detection for Medical Images

Due to the high cost of manually annotating medical images, especially for large-scale datasets, anomaly detection has been explored through training models with only normal data. Lacking prior knowledge of true anomalies is the main reason for the limited application of previous anomaly detection methods, especially in the medical image analysis realm. In this work, we propose a one-shot anomaly detection framework, namely LesionPaste, that utilizes true anomalies from a single annotated sample and synthesizes artificial anomalous samples for anomaly detection. First, a lesion bank is constructed by applying augmentation to randomly selected lesion patches. Then, MixUp is adopted to paste patches from the lesion bank at random positions in normal images to synthesize anomalous samples for training. Finally, a classification network is trained using the synthetic abnormal samples and the true normal data. Extensive experiments are conducted on two publicly-available medical image datasets with different types of abnormalities. On both datasets, our proposed LesionPaste largely outperforms several state-of-the-art unsupervised and semi-supervised anomaly detection methods, and is on a par with the fully-supervised counterpart. To note, LesionPaste is even better than the fully-supervised method in detecting early-stage diabetic retinopathy.